Skip to content
★ Sign in to follow
SC

Sanat Chattopadhyay

Vice-président exécutif et président
Merck & Co., Inc.
Total declarations
43
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€42.2M

Latest filing published 01 May 2026 for Merck & Co., Inc., €245k.

Filing timeline

BuySale
Sanat Chattopadhyay

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

Sanat Chattopadhyay: trading record in brief

Sanat Chattopadhyay, Exe V-P & Pres. MMD at Merck & Co., Inc., has filed 12 sales worth EUR 42.2 million, a median of EUR 2,767,470 per sale. The three largest: EUR 10,071,656 on October 28, 2022, then EUR 7,067,036 and EUR 6,886,462, both on April 13, 2023. No purchase appears.

Around those sales, the record holds 43 filings published from May 9, 2016 to May 1, 2026: 16 option exercises and 15 grants. The year 2023 gathers 11, well ahead of the others, which range from 1 to 6. Only 1 filing is published in 2024 and 1 in 2025, then 3 in 2026, which are also the 3 in the last twelve months, none of them a sale.

Delays stay short, a median of 2 days.

At Merck & Co., Inc., 8 of Chattopadhyay's market trades fall within 30 days of a trade by Jennifer Zachary, and the same number of one by Steven Mizell, all in the same direction. Rita A. Karachun counts 6, Kenneth C. Frazier and Richard R. DeLuca 4 each.

Companies and markets linked to Sanat Chattopadhyay

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total

25 of 43 declarations